Satellos Bioscience Inc. (MSLE) stock
MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.20−0.27 (-4.17%)
Close on Nov 17, 2026Market cap $95.85MP/E –Yield –
Satellos Bioscience operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$26.46M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.46M | – |
| FY2024 | Dec 31, 2024 | -$20.40M | – |
See a number that looks wrong?